TONIX PHARMACEUTICALS HLDG C's ticker is TNXP and the CUSIP is 890260201. A total of 29 filers reported holding TONIX PHARMACEUTICALS HLDG C in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $22,000 | -31.2% | 46,543 | 0.0% | 0.00% | – |
| Q3 2016 | $32,000 | -65.6% | 46,543 | 0.0% | 0.00% | – |
| Q2 2016 | $93,000 | -17.0% | 46,543 | 0.0% | 0.00% | – |
| Q1 2016 | $112,000 | -68.6% | 46,543 | 0.0% | 0.00% | – |
| Q4 2015 | $357,000 | +45.1% | 46,543 | 0.0% | 0.00% | – |
| Q3 2015 | $246,000 | – | 46,543 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 370,000 | $1,602,000 | 0.67% |